Use of novel antiretroviral agents in rescue regimens: a case of early virological failure to raltegravir.
Author(s): Tommasi C, Ceccherini-Silberstein F, D'Arrigo R, Bellagamba R, Tempestilli M, Dessi C, Santoro MM, Forbici F, Nicastri E, Pucillo LP, Perno CF, Narciso P
Affiliation(s): National Institute for Infectious Diseases, INMI, L Spallanzani, Rome, Italy.
Publication date & source: 2010-03, Scand J Infect Dis., 42(3):237-9.
Publication type: Case Reports
In patients with virological failure during highly active antiretroviral therapy (HAART) and drug resistance, guidelines recommend the achievement of maximal virological suppression by the use of a new regimen with at least 2 active drugs. We describe the clinical outcome of a heavily antiretroviral-experienced patient who experienced early failure to raltegravir.
|